Submit Phase III clinical trial report up to 180 days: CDSCO Panel Tells Bharat Biotech on Oral Cholera Vaccine Dr. Divya Colin30 July 2023 12:30 PM GMTNew Delhi: In response to the proposal presented by the vaccine maker Bharat Biotech to manufacture Cholera Vaccine (Inactivated, Oral), the Subject...
Design protocol as Phase III CT for 1 to more than 50 years age group: CDSCO panel tells Bharat Biotech on JE vaccine Dr. Divya Colin14 July 2023 12:30 PM GMTNew Delhi: In response to the proposal presented by the vaccine maker Bharath Biotech to conduct the Phase IV clinical trial of the Japanese...
Bharat Biotech's intranasal Covid vaccine iNCoVACC gets CDSCO Panel nod for PMS study Susmita Roy1 May 2023 12:30 PM GMTNew Delhi: In a significant development, the vaccine manufacturer Bharat Biotech International Limited has got a go-ahead from the Subject Expert...
Bharat Biotech dispatches first shipments of World's first intranasal COVID vaccine iNCOVACC across India Ruchika Sharma7 Feb 2023 9:45 AM GMTIt is a Covid19 vaccine that does not require syringes, needles, alcohol wipes, bandages, etc, saving costs related to procurement, distribution,...
State drugs regulators should be merged with CDSCO to ensure "one quality one standard": Bharat Biotech MD Ruchika Sharma6 Feb 2023 9:45 AM GMTIt is important to centralise the system, Krishna Ella said.
Bharat Biotech dispatches three lakh doses of intranasal COVID vaccine to hospitals Ruchika Sharma6 Feb 2023 4:30 AM GMTiNCOVACC is the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose for...
Dr Mansukh Mandaviya unveils Bharat Biotech intransal COVID vaccine iNCOVACC Ruchika Sharma27 Jan 2023 6:42 AM GMTiNCOVACC is a cost-effective covid vaccine which does not require syringes, needles, alcohol wipes, bandage, etc, saving costs related to procurement,...
Intranasal COVID vaccine: Bharat Biotech to launch iNCOVACC on January 26 MD Bureau23 Jan 2023 5:45 AM GMTINCOVACC is a nasal vaccine indicated for active immunization against SARS-CoV-2 virus infection.
Bharat Biotech founder Dr Krishna Ella bats for incentives, tax breaks for patented products, innovation Ruchika Sharma21 Jan 2023 6:45 AM GMTQueried about the need for three doses of the COVID-19 vaccine instead of just one, Ella said his company was working on the issue.
Health Ministry shocker in RTI reply: CDSCO, ICMR admit to multiple side effects of Covid-19 jabs Farhat Nasim17 Jan 2023 8:34 AM GMTNew Delhi: In a shocking response to an RTI query, the Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research...
Delhi High Court makes Bharat Biotech, Centre parties in pleas seeking details on COVID vaccine Covaxin Ruchika Sharma11 Jan 2023 9:26 AM GMTThree petitions challenging the Central Information Commission's (CIC) decision to withhold the facts on the grounds of trade secrets, intellectual...
Conduct trial with additional safety arm of 1800 subjects: CDSCO Panel Tells Bharath Biotech on Cholera Vaccine Dr. Divya Colin10 Jan 2023 12:30 PM GMTNew Delhi: Regarding the already approved Phase III clinical trial protocol of Cholera Vaccine (Inactivated Vibrio cholarae, MS 1568, Oral), the...
